ViCardia

San Francisco, United States

ViCardia is a clinical-stage biopharmaceutical company.

$700K raised

May 2026

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ViCardia

How much funding has ViCardia raised?

ViCardia has raised $700K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.

Where is ViCardia headquartered?

ViCardia is headquartered in San Francisco, United States.

What does ViCardia do?

ViCardia is a clinical-stage biopharmaceutical company.

What stage is ViCardia at?

ViCardia is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 21, 2026.

MLA

"ViCardia — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/vicardia. Accessed July 4, 2026.

APA

VCBacked. (2026). ViCardia — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/vicardia

Wikipedia (cite web)

{{cite web |title=ViCardia — Funding & Investors |url=https://www.vcbacked.co/company/vicardia |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 21, 2026.